Pemafibrate, as a novel selective PPAR α agonist, has side effects mainly involving liver dysfunction and muscle symptoms, most of which can be...
Pemafibrate, as a novel lipid-lowering drug, is mainly used for the treatment of specific types of hyperlipidemia. Its use requires special att...
Erivedge, as an inhibitor of the Hedgehog signaling pathway, has clear contraindications, dietary restrictions, and medication constraints when...
As a targeted drug for the treatment of basal cell carcinoma, the usage and dosage of Erivedge should strictly follow the weight standard, and ...
The contraindications for perfluorohexane octane eye drops (Miebo) involve individuals with special physiological conditions and allergies, and...
Perfluorohexyl octane eye drops (Miebo) are an innovative artificial tear substitute for the treatment of dry eye syndrome. Their indications a...
Valemetostat, as an EZH2 inhibitor, is contraindicated mainly to individuals with special physiological conditions and drug interaction risks. ...
Valemetostat, as an EZH2 inhibitor, should be adjusted in dosage according to indications for standard use. Special attention should be paid to...
Elaszym, as a protein hydrolase preparation, is mainly used to improve chronic inflammatory diseases and metabolic abnormalities. Its mechanism...
Elaszym has shown multi-target therapeutic effects in chronic inflammation and metabolic diseases, and its discontinuation needs to be graduall...